ENTRY       D09947                      Drug
NAME        Peginesatide acetate (JAN/USAN);
            Omontys (TN)
FORMULA     C231H350N62O58S6(C2H4O)n. (C2H4O)2
REMARK      ATC code: B03XA04
            Chemical structure group: DG00178
EFFICACY    Anti-anemic, Erythropoietin receptor agonist
COMMENT     a functional analog of erythropoietin [HSA:2056] [KO:K05437]
            Treatment of anemia associated with chronic kidney disease
TARGET      EPOR [HSA:2057] [KO:K05079]
  PATHWAY   hsa04060(2057)  Cytokine-cytokine receptor interaction
            hsa04630(2057)  JAK-STAT signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03X OTHER ANTIANEMIC PREPARATIONS
                B03XA Other antianemic preparations
                 B03XA04 Peginesatide
                  D09947  Peginesatide acetate (JAN/USAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                EPOR
                 D09947  Peginesatide acetate (JAN/USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09947
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09947
DBLINKS     CAS: 1185870-58-9
            PubChem: 124490629
            ChEBI: 66895
///
